References
Scillitani A, Mazziotti G, Di Somma C, Moretti S, Stigliano A, Pivonello R, Giustina A, Colao A, ABC Group (2014) Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int 25:441–446. doi:10.1007/s00198-013-2588-y
Miller BS, Ignatoski KM, Daignault S, Lindland C, Gauger PG, Doherty GM, Wang SC, University of Michigan Analytical Morphomics Group (2011) A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolism. Surgery 150:1178–1185
Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21:543–559
Tosteson AN, Gottlieb DJ, Radley DC, Fisher ES, Melton LJ 3rd (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463–1472
Srikanthan P, Karlamangla AS (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 96:2898–2903
Muscaritoli M, Lucia S, Molfino A, Cederholm T, Rossi Fanelli F (2013) Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia? Intern Emerg Med 8:553–560
Ferrando AA, Stuart CA, Sheffield-Moore M, Wolfe RR (1999) Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 84:3515–3521
Binkley N, Krueger D, Buehring B (2013) What’s in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?". Osteoporos Int 24:2955–2959
Rittweger J, Simunic B, Bilancio G, De Santo NG, Cirillo M, Biolo G, Pisot R, Eiken O, Mekjavic IB, Narici M (2009) Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone 44:612–618
Biolo G, Heer M, Narici M, Strollo F (2003) Microgravity as a model of ageing. Curr Opin Clin Nutr Metab Care 6:31–40
Cianferotti L, Brandi ML (2014) Muscle-bone interactions: basic and clinical aspects. Endocrine 45:165–177
Braun T, Schett G (2012) Pathways for bone loss in inflammatory disease. Curr Osteoporos Rep 10:101–108
Romme EA, Smeenk FW, Rutten EP, Wouters EF (2013) Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med 7:397–410
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692
Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B (2011) Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 93:402–412
Orchard TS, Pan X, Cheek F, Ing SW, Jackson RD (2012) A systematic review of omega-3 fatty acids and osteoporosis. Br J Nutr 107:S253–S260
Kim H (2012) Interventions for frailty and sarcopenia in community-dwelling elderly women. Nihon Ronen Igakkai Zasshi 49:726–730
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Molfino, A., Aversa, Z. & Muscaritoli, M. Cortisol and the muscle-bone axis. Osteoporos Int 25, 2331–2332 (2014). https://doi.org/10.1007/s00198-014-2784-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2784-4